Merck & Company (CH:6MK)
NYSE:6MK
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 64.93B | $ 64.17B | $ 60.12B | $ 59.28B | $ 48.70B |
| Gross Profit | $ 46.73B | $ 48.98B | $ 43.99B | $ 41.87B | $ 35.08B |
| Operating Income | $ 23.49B | $ 20.22B | $ 2.95B | $ 18.28B | $ 13.20B |
| EBITDA | $ 28.26B | $ 25.71B | $ 6.91B | $ 21.32B | $ 17.90B |
| Net Income | $ 18.25B | $ 17.12B | $ 365.00M | $ 14.52B | $ 13.05B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 14.56B | $ 13.69B | $ 7.09B | $ 13.19B | $ 8.10B |
| Total Assets | $ 136.87B | $ 117.11B | $ 106.67B | $ 109.16B | $ 105.69B |
| Total Debt | $ 50.53B | $ 38.27B | $ 36.27B | $ 31.98B | $ 34.63B |
| Net Debt | $ 35.97B | $ 25.03B | $ 29.43B | $ 19.29B | $ 26.54B |
| Total Liabilities | $ 84.20B | $ 70.73B | $ 69.04B | $ 63.10B | $ 67.44B |
| Stockholders' Equity | $ 52.61B | $ 46.31B | $ 37.58B | $ 45.99B | $ 38.18B |
| Cash Flow | |||||
| Free Cash Flow | $ 12.36B | $ 18.10B | $ 9.14B | $ 14.71B | $ 9.66B |
| Operating Cash Flow | $ 16.47B | $ 21.47B | $ 13.01B | $ 19.09B | $ 14.11B |
| Investing Cash Flow | $ -13.74B | $ -7.73B | $ -14.08B | $ -4.96B | $ -16.55B |
| Financing Cash Flow | $ -1.92B | $ -7.03B | $ -4.81B | $ -9.12B | $ 2.59B |